Tap water contains hidden danger linked to harm for unborn babies
Columbia University researchers found pregnant woman exposed to even trace amounts in drinking water were much more likely to have premature births or have underweight kids. Children born preterm or underweight face lifelong risks—impaired cognition, developmental delays, and chronic diseases like diabetes, heart disease, and immune deficiencies. Arsenic crosses the placenta and disrupts fetal development by interfering with hormones, DNA expression, and organ formation.
It also disrupts nutrient absorption, stunting growth, and triggers inflammation, raising the risk of an early birth. The EPA's current max contamination limit (MCL) for arsenic in drinking water is 10 micrograms per liter (μg/L). But the researchers found: 'Higher prenatal public water arsenic was associated with lower birth weight, reduced birth weight–for–gestational age...and a higher risk of low birth weight even at concentrations less than 5 μg/L.' Arsenic seeps into groundwater and contaminates the supply that ultimately reaches tap water in homes. An estimated 2.1 million people throughout the US may be drinking domestic well water high in arsenic.
The element has also been found in municipal water supplies in all 50 states. Up to 280 million people rely on public water systems. The greatest concern is water systems in the Southwest due to arsenic-rich rocks and arsenic-rich volcanic and sedimentary rock erosion. The new paper, funded by the NIH, analyzed data from a nationwide research project called the ECHO Cohort, which tracks over 69 different groups of pregnant women and children across the US and Puerto Rico. It revealed white mothers were most exposed to higher arsenic levels – over 10 micrograms per liter (μg/L) in public water - making up 69 percent of this group.
Slightly under eight percent had underweight newborns,1,190 of 14,000 births births came too early, 840 infants were critically small, and 1,400 babies were dangerously undersized for their stage of development. This study revealed racial and ethnic disparities in birth outcomes. Hispanic/Latino mothers had healthier babies—higher birth weights and fewer complications—than non-Hispanic/Latino mothers. In contrast, Black mothers' babies were, on average, 245 grams lighter and faced higher risks of preterm birth, low birth weight, and being small for gestational age. 'Most U.S. residents rely on public drinking water, and our findings suggest that further reducing arsenic in public water systems could be an important step to improve infant health across the U.S.,' said Dr Anne Nigra, PhD, an environmental health scientist at Columbia's Mailman School of Public Health. 'Even low levels of arsenic in public drinking water were associated with low birthweight and other adverse birth outcomes in U.S. infants.'
Long-term exposure has been linked to leukemia and cancers of the colon, skin, breast, stomach, mouth, kidney, and more, as well as heart disease. Even tiny amounts of inorganic arsenic — the kind found in drinking water — wreak havoc on your cardiovascular system by causing oxidative stress that can kill cells, inflammation that damages blood vessels, and stiff, damaged arteries. 'Most U.S. residents rely on public drinking water, and our findings suggest that further reducing arsenic in public water systems could be an important step to improve infant health across the U.S.,' said Dr Anne Nigra, an environmental health expert at Columbia University 's Mailman School of Public Health.
The Columbia researchers behind the latest study analyzed arsenic exposure in 14,000 US pregnancies by linking EPA water system data recorded from 2006 to 2019 to records of where the participants lived during pregnancy. Researchers tracked monthly water arsenic levels and examined four birth outcomes: preterm delivery, low birth weight, small gestational size, and birth weight scores. The analysis accounted for factors like maternal age and education while intentionally preserving racial/ethnic differences.
Even small increases in arsenic levels (one μg/L) in public water raised low birth weight risks by three percent, with higher exposures (five μg/L) increasing risks by 16 percent. They reported some caveats. The majority of ECHO participants reside in urban areas. They estimated arsenic exposure based on local water systems near people's homes, but they do not yet know if this fully captures their actual exposure. People do not just drink water at home. They are also exposed at work, school, or other places they go to frequently. The researchers' findings were published in the journal JAMA Network Open.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
2 hours ago
- Times
My brother died at 33 — what I wish I'd known
I remember seeing the troubling spark of recognition in the psychologist's eyes when I told her that my late brother, Charlie, had schizophrenia. We were sitting in her office going through a never-ending pile of forms as part of my seven-year-old son Eddie's autism-assessment process, including my family history. 'Did you know,' she asked, 'that autism used to be known as childhood schizophrenia?' I remember the grating rough texture of the chair I was sitting on prickling against the back of my legs and feeling the inside of my stomach flip. We lost my big brother, Charlie, in 2004 when he was 33 and he hadn't had a particularly happy life. He had been diagnosed with schizophrenia at the age of 18 after a period of psychosis — he had been hearing voices and became convinced that a group of people were out to get him.
The Independent
2 hours ago
- The Independent
Weight loss pill set to rival injections after promising studies
A new daily weight loss pill has shown promising results in initial studies. Researchers say amycretin, which can be offered by injection or tablet, helped patients lose a significant amount of weight in the first trials. Those who received higher doses of amycretin as a weekly jab lost 24.3 per cent of their body weight after 36 weeks of treatment, while patients who took daily tablets lost an average of 13.1 per cent of their body weight after 12 weeks. While weight loss jabs have been hailed as transformative by NHS leaders, injections come with additional work for over-stretched health services, so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3 per cent after 36 weeks of treatment. It also showed signs of improving blood sugar levels. Side effects included nausea and vomiting, and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1 per cent of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association 's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7 per cent, with a third of participants losing 25 per cent or more of their body weight after 72 weeks.
Reuters
3 hours ago
- Reuters
Wreck of 17th century Swedish warship found off Finland
Researchers have identified a shipwreck off Porkkala, in southern Finland, as the Swedish warship 'Falken,' a 17th-century vessel built in Stockholm and considered the 'little sister' of the iconic Vasa ship.
